Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
Key facts
- Who runs it
- Istanbul University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 40 people, planned
- Started
- 5 Nov 2025
- Planned end
- 15 Jul 2026
- Type of study
- Observational
- Treatments tested
- mobile application
- Record updated
- 3 December 2025
Who can take part
- Age
- 8 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Children and adolescents aged 8-18 years
- FMF diagnosis established by Tel Hashomer and/or Eurofever criteria
- Regular follow-up at the participating pediatric rheumatology clinic
- Stable treatment regimen, defined as:
- Colchicine use for ≥ 4 weeks
- Biologic or other anti-inflammatory agents stable for ≥ 8 weeks (if applicable)
- Access to a smartphone or tablet (iOS/Android) with internet and ability to use the study mobile application (caregiver assistance allowed)
- Language proficiency (patient and/or caregiver) sufficient to use the app and respond to prompts
- Informed consent from a parent/guardian and assent from the child, as appropriate
Who cannot take part
- Known primary or secondary immunodeficiency or ongoing immunosuppressive chemotherapy outside standard FMF care
- Concurrent participation in another clinical study likely to affect outcomes or reporting
- Co-existing chronic inflammatory or autoimmune disorders that may confound flare/infection assessment (e.g., JIA, IBD, Behçet disease) other than FMF
- Chronic active infection (e.g., TB, HBV, HCV, HIV) or acute febrile illness at enrollment precluding baseline assessment
- Cognitive, visual, or motor limitations preventing app use without caregiver support
- No reliable access to a compatible device or internet connection
- Anticipated non-adherence (e.g., inability to complete app entries) as judged by the investigator
- Refusal or withdrawal of consent/assent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 18 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent episodes of fever, abdominal pain, and serositis. FMF attacks often present with fever and systemic symptoms resembling infectious diseases, making it challenging in clinical practice to distinguish between an attack and an infection. Moreover, infections are known to trigger FMF attacks; however, the number of prospective studies evaluating this association remains limited.
Read full original descriptionShow less
In the current literature, the frequency of attacks and triggering factors in FMF patients have mostly been assessed through retrospective chart reviews. Such methods are prone to incomplete or recall-based data regarding the onset of attacks and infection-related symptoms. With the growing availability of digital health applications, it has become possible to record disease symptoms in real time and on a regular basis, providing more reliable data for both clinicians and researchers.
The present study aims to prospectively evaluate the relationship between infections and disease flares in FMF patients by systematically recording infection symptoms and attack characteristics through a mobile application. This approach is intended to achieve a better understanding of the infection-flare association, improve patient management, and prevent unnecessary treatments. In addition, the feasibility of mobile application-based patient monitoring will be assessed, and its potential contribution to routine clinical practice will be explored.
The group in the trial
- FMF group
Patients aged 6-18 years with a diagnosis of FMF according to the Tel Hashomer and Eurofever criteria who agreed to use the mobile application
Treatment: mobile application
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Monitoring Infection Symptoms Through a Mobile Application and Their Effect on Disease Flares in Familial Mediterranean Fever Patients
- Criteria questions
- Built from NCT07212764, who can take part
- Record updated
- 3 December 2025